HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.

Abstract

To reassess the effect of modafinil, a wakefulness-promoting artificial psychostimulant, on fatigue and neuropsychological measures in patients with multiple sclerosis.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer8
ISSN1352-4585
StatusVeröffentlicht - 2011
pubmed 21561959